Roflumilast CAS:162401-32-3

Roflumilast is indicated for the maintenance treatment of severe COPD associated with chronic bronchitis and a history of frequent exacerbations. It helps to reduce inflammation in the airways, leading to improved lung function and decreased exacerbations. Roflumilast is not a bronchodilator and should not be used for the relief of acute bronchospasm. This medication is typically used in addition to other treatments for COPD, such as bronchodilators. In summary, Roflumilast plays a crucial role in managing severe COPD by reducing inflammation in the airways, improving lung function, and decreasing the frequency of COPD exacerbations. Always seek medical advice from a healthcare professional for personalized information.